Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine

BACKGROUND: A new nonavalent human papillomavirus (HPV) vaccine that includes genotypes 6/11/16/18/31/33/45/52/58 has been recently approved in Spain. A previous study has shown that attributable fraction of HPV related diseases in Spain is consistent with that reported in European and global studie...

Descripción completa

Detalles Bibliográficos
Autores principales: López, Noelia, Torné, Aureli, Franco, Agustín, San-Martin, María, Viayna, Elisabet, Barrull, Carmen, Perulero, Nuria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930836/
https://www.ncbi.nlm.nih.gov/pubmed/29743937
http://dx.doi.org/10.1186/s13027-018-0187-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930836/
https://www.ncbi.nlm.nih.gov/pubmed/29743937
http://dx.doi.org/10.1186/s13027-018-0187-4

Ejemplares similares